Hem › Precursor-T-cells leukemisk lymfom › New York
Kliniska studier för Precursor-T-cells leukemisk lymfom i New York
7 studier för Precursor-T-cells leukemisk lymfom söker deltagare vid platser i New York.
Städer i New York
Officiell studietext (engelska)
A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)
- Memorial Sloan Kettering Cancer Center -- Pediatrics, New York
RekryterarFas 2
6 Months · Alla kön · Uppdaterad 28 sep. 2026 · NCT06514794Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATLL)
- Memorial Sloan Kettering Commack, Commack
- Memorial Sloan Kettering Westchester, Harrison
- Memorial Sloan Kettering Cancer Center, New York
- och 1 fler
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 23 sep. 2026 · NCT04301076Targeted Immunotherapy After Myeloablative TBI-Based Conditioning & AlloHCT in CAYA With High Risk T-Cell ALL & Lymphoma
- New York Medical College, Vallhala
RekryterarFas 1
Upp till ålder 39 · Alla kön · Uppdaterad 11 sep. 2026 · NCT04972942A Registry for People With T-cell Lymphoma
- Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (All protocol activities), Commack
- Memorial Sloan Kettering Westchester (All protocol activities), Harrison
- Weill Cornell Medical Center (Data Collection Only), New York
- och 2 fler
RekryterarObservationsstudie
Alla åldrar · Alla kön · Uppdaterad 20 maj 2026 · NCT05978141Study of Mogamulizumab With DA-EPOCH or CHOEP in Patients With Aggressive T-cell Lymphoma
- Icahn School of Medicine at Mount Sinai, New York
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 14 apr. 2026 · NCT05996185A Study of Mogamulizumab to Prevent Adult T-cell Leukemia/Lymphoma in People With HTLV-1
- Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (All protocol activities), Commack
- Memorial Sloan Kettering Westchester (All protocol activities), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- och 1 fler
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 5 mars 2026 · NCT06698003Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)
- Memorial Sloan Kettering Cancer Center, New York
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 15 apr. 2025 · NCT06462365Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.